Today, hundreds of thousands of patients worldwide with autoimmune diseases, including psoriasis, are treated with anti-inflammatory cytokines that inhibit IL-1, although a small percentage of those treated may develop bacterial infections. The gene discussed is IL1B; the disease is psoriasis.